Project Grant R35GM162552
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $226,404 to Harvard College's Office For Sponsored Programs on June 22, 2026, with a completion date of February 28, 2029, under the Biomedical Research and Research Training program (CFDA 93.859). The research project addresses selective N-alkylation of azoles via anion-binding catalysis, focusing on developing innovative synthetic methods to selectively modify azole...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard Medical School $154,664 under the Biomedical Research and Research Training program (CFDA 93.859) on January 31, 2026, to support fundamental research into the cellular mechanisms of organelle integration in photosynthetic sea slugs. The project, scheduled for completion by November 30, 2028, will deliver scientific research outputs focused on understanding how sacoglossan sea slugs maintain...
- Federal Project Grant Award Summary Harvard College received a $508,111 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. This award supports fundamental research investigating the molecular basis and selectivity of signaling and transport mechanisms across lipid membranes, with emphasis on bacterial membrane protein systems containing common...
- Federal Grant Award Summary Harvard College received a $1.6 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 10, 2026, with completion targeted for February 28, 2030. The grant supports fundamental research examining the physical mechanisms by which bacterial cell division machinery deforms and constricts bacterial membranes during cell division. Specifically, the...
- Federal Project Grant Award Summary President and Fellows of Harvard College, operating through Harvard Medical School, received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 17, 2025, with completion targeted for June 30, 2027. The award supports fundamental research aimed at elucidating the molecular mechanisms of selective Golgi remodeling through...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard Medical School a $2.53 million Project Grant (CFDA 93.859: Biomedical Research and Research Training) beginning September 1, 2025, and extending through August 31, 2029. This R35 Maximizing Investigators' Research Award (MIRA) supports fundamental research on sample multiplexing as an enabling technology for quantitative proteomics. The research aims to advance mass spectrometry (MS)-based...
- Federal Grant Award Summary Harvard Medical School received a $570,760 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025 through August 31, 2030. This five-year research initiative will generate mechanistic and structural insights into intraflagellar transport (IFT) in Leishmania species, parasitic organisms responsible for leishmaniasis and other...
- Federal Project Grant Award Summary Harvard College's Office for Sponsored Programs received a $531,280 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on June 20, 2025, with a completion date of December 31, 2026. This research initiative investigates the developmental origins of adult pluripotent stem cells (APSCs) in the regenerative organism Hofstenia, focusing on identifying...
- Federal Grant Award Summary Harvard Medical School received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, with a completion date of March 31, 2028. The award supports the development and deployment of bacterial transcription factor (TF) biosensors to accelerate pharmaceutical biocatalyst engineering. The project addresses manufacturing bottlenecks...
- Federal Project Grant Award Summary Harvard Medical School, through its Office of Research Administration division, received a $540,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on September 10, 2025. The award, with a completion date of August 31, 2030, funds the expansion and enhancement of MicroTutor, an innovative online educational platform designed to train a new generation...
The National Institute of General Medical Sciences (NIGMS) awarded Harvard College a Project Grant of $463,375 under the Biomedical Research and Research Training program (CFDA 93.859) on April 1, 2026, with a completion date of February 28, 2031. The award supports fundamental research investigating the mechanisms by which the fungus Entomophthora muscae manipulates the behavior of its host, the fruit fly Drosophila melanogaster. The research aims to decode the fungal triggers and neural targets involved in behavior manipulation, specifically focusing on the fungal genes responsible for inducing "summiting behavior" (wherein infected flies are driven to climb), the molecular cues that trigger this behavior, the necessity of central nervous system invasion, and the identification of specific neurons directly influenced during manipulation. The research employs an interdisciplinary approach integrating neurobiology, genetics, and microbiology methodologies. Key research activities include real-time behavioral classification, single-cell messenger RNA sequencing, and metabolomics analysis to uncover the molecular, genetic, and neural circuit mechanisms underlying fungal-induced behaviors. Additionally, the project seeks to establish transgenic access to E. muscae and advance the field of neuroparasitology beyond correlative studies toward causal mechanisms linking parasite genes to host behavior. The research is performed at Harvard College's Cambridge, Massachusetts facility and is anticipated to yield novel insights into neural circuit functionality and potential therapeutic applications of fungal natural products.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $463.4k | 3/24/26 |